de Velasco, G. Et Al. 2016. Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. EUROPEAN UROLOGY FOCUS , vol.2, no.6 , 633-639.

de Velasco, G., Gray, K. P., Hamieh, L., ÜRÜN, Y., Carol, H. A., Fay, A. P., ... Signoretti, S.(2016). Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. EUROPEAN UROLOGY FOCUS , vol.2, no.6, 633-639.

de Velasco, Guillermo Et Al. "Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma," EUROPEAN UROLOGY FOCUS , vol.2, no.6, 633-639, 2016

de Velasco, Guillermo d. Et Al. "Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma." EUROPEAN UROLOGY FOCUS , vol.2, no.6, pp.633-639, 2016

de Velasco, G. Et Al. (2016) . "Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma." EUROPEAN UROLOGY FOCUS , vol.2, no.6, pp.633-639.

@article{article, author={Guillermo de Velasco Et Al. }, title={Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma}, journal={EUROPEAN UROLOGY FOCUS}, year=2016, pages={633-639} }